Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Aug 8;178:113918. doi: 10.1016/j.addr.2021.113918

Figure 2.

Figure 2.

Nanomedicine based approaches for delivering HuR siRNA in LC cells. (A) Schematic representation of synthesis and TEM characterization of HuR siRNA – folate nanoparticle (FNP) prepared with DOTAP: Cholesterol, and (B) reduced expression of HuR in mouse A549 LC models treated with HuR – transferrin liposomal nanoparticle (TfNP) when compared to control. Image reproduced from Muralidharan et al., 2016 [148] and Muralidharan et al., 2017 [149] that is under an open access Creative Commons CC BY 4.0 licence.